# TEMBEXA
> **NDA214461** · New Drug Application · Sponsor: EMERGENT BIODEFENSE · Approved 2021-06-04
## Drug
- **FDA Application Number:** NDA214461
- **Application type:** New Drug Application
- **Brand name:** TEMBEXA
- **Generic name:** BRINCIDOFOVIR
- **Active ingredients:** BRINCIDOFOVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EMERGENT BIODEFENSE
- **Manufacturer:** Emergent BioDefense Operations Lansing LLC
- **First approval:** 2021-06-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214461)
---
*MORVS · CC0 1.0*